MEDIROM Healthcare Technologies Free Cash Flow 2021-2023 | MRM

MEDIROM Healthcare Technologies free cash flow from 2021 to 2023. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
MEDIROM Healthcare Technologies Annual Free Cash Flow
2022 -5.90
2021 -5.94
2020 -4.11
2019
MEDIROM Healthcare Technologies Quarterly Free Cash Flow
2022-12-31
2022-06-30
2021-12-31
2021-06-30
2020-12-31
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.027B $0.053B
MEDIROM Healthcare Technologies Inc. is a holistic healthcare company. MEDIROM Healthcare Technologies Inc. is based in NEW YORK.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $17.429B 10.54
Quest Diagnostics (DGX) United States $15.377B 15.89
DaVita (DVA) United States $12.061B 14.98
Encompass Health (EHC) United States $8.712B 22.30
Chemed (CHE) United States $8.709B 26.99
Elanco Animal Health (ELAN) United States $8.401B 21.79
Option Care Health (OPCH) United States $5.235B 19.82
RadNet (RDNT) United States $4.083B 85.00
Amedisys (AMED) United States $3.121B 22.11
LifeStance Health (LFST) United States $2.622B 0.00
Astrana Health (ASTH) United States $2.179B 29.46
Addus HomeCare (ADUS) United States $1.789B 25.59
U.S Physical Therapy (USPH) United States $1.603B 42.90
Pennant (PNTG) United States $0.680B 35.94
Aveanna Healthcare Holdings (AVAH) United States $0.481B 0.00
Atai Life Sciences (ATAI) Germany $0.316B 0.00
Daxor (DXR) United States $0.045B 0.00
ATI Physical Therapy (ATIP) United States $0.022B 0.00
Psychemedics (PMD) United States $0.015B 0.00
Ontrak (OTRK) United States $0.013B 0.00
Novo Integrated Sciences (NVOS) United States $0.011B 0.00
IMAC Holdings (BACK) United States $0.004B 0.00